Previous Article | Next Article ![]()
Infection and Immunity, August 2001, p. 4782-4789, Vol. 69, No. 8
Department of Pathology and Laboratory
Medicine1 and Department of
Medicine,3 University of Pennsylvania
Medical School, Philadelphia, PA 19104-4283, and First
Department of Internal Medicine, Faculty of Medicine, University of
the Ryukyus, Okinawa 903-0215, Japan2
Received 26 October 2000/Returned for modification 5 February
2001/Accepted 2 May 2001
We previously identified the Legionella pneumophila
ptsP (phosphoenolpyruvate phosphotransferase) ortholog gene as a
putative virulence factor in a study of signature-tagged mutagenesis
using a guinea pig pneumonia model. In this study, we further defined the phenotypic properties of L. pneumophila ptsP and its
complete sequence. The L. pneumophila ptsP was 2,295 bases
in length. Its deduced amino acid sequence had high similarity with
ptsP orthologs of Pseudomonas aeruginosa, Azotobacter
vinelandii, and Escherichia coli, with nearly
identical lengths. Here we show that while the mutant grew well in
laboratory media, it was defective in both lung and spleen
multiplication in guinea pigs. It grew slowly in guinea pig alveolar
macrophages despite good uptake into the cells. Furthermore, there was
minimal growth in a human alveolar epithelial cell line (A549).
Transcomplementation of the L. pneumophila ptsP mutant
almost completely rescued its growth in alveolar macrophages, in A549
cells, and in guinea pig lung and spleen. The L. pneumophila ptsP mutant was capable of evasion of phagosome-lysosome fusion and resided in ribosome-studded phagosomes. Pore formation activity of
the mutant was normal. The L. pneumophila ptsP mutant
expressed DotA and IcmX in apparently normal amounts, suggesting that
the ptsP mutation did not affect dotA and
icmX regulation. In addition, the mutant was resistant to
serum and neutrophil killing. Taken together, these findings show that
L. pneumophila ptsP is required for full in vivo virulence
of L. pneumophila, most probably by affecting intracellular growth.
Legionella pneumophila is
the most common etiologic agent of Legionnaires' disease, a type of
pneumonia affecting immunocompromised and immunocompetent humans
(13). This gram-negative bacterium is a facultative
intracellular parasite of mononuclear cells in vivo and in vitro
(19) and evades phagosome-lysosome fusion within these
cells (16). The phagosomes harboring L. pneumophila are studded by ribosomes during certain periods
(37). Several L. pneumophila virulence factors
facilitating intracellular growth have been identified in screens using
macrophages or macrophage-like cell lines (24, 25). One
important set of virulence factors is the dot/icm system,
which is required for evasion of phagosome-lysosome fusion (3,
34, 35) and establishment of the phagosomes permissive for
growth of L. pneumophila within them (6).
In a previous study, we described a broad range of potential L. pneumophila virulence genes in a guinea pig pneumonia model by
using a signature-tagged mutagenesis method (12). In that study, three different classes of macrophage virulence phenotypes were
discovered. One group of mutants had a markedly reduced ability to
multiply within macrophages and included mutants of the already known
dot/icm complex (3, 35). Another group of
mutants was able to multiply efficiently within macrophages. A third
group of mutants had an initial defect in intracellular multiplication but were able to multiply in macrophages as well as the wild-type strain after prolonged incubation. Partial sequencing of the
transposon-interrupted genes of two prototrophic mutants of this third
group showed homology to the Escherichia coli
phosphoenolpyruvate phosphotransferase (ptsP)
(33).
The E. coli ptsP ortholog facilitates nitrogen utilization
via a complex two-component sensing and regulatory phosphate transfer system. The E. coli ptsP gene encodes enzyme
INtr (EINtr), consisting of two domains: an
N-terminal domain of 127 amino acids homologous to the N-terminal
sensory domain of the NifA protein of Azoto bacter
vinelandii, and a C-terminal domain of 578 amino acids homologous
to all other currently sequenced EI proteins (33).
Sequence analysis suggests that EINtr serves a sensory
function linking carbon and nitrogen metabolism (33). The
C-terminal domain of EINtr transfers a phosphate from
phosphoenolpyruvate to a histidine residue of the phosphocarrier
protein NPr (32). NPr in turn transfers a phosphate to the
cell membrane EIIANtr, which has a role in the regulation
of In this study, the L. pneumophila ptsP ortholog gene was
completely sequenced and its deduced amino acid sequence was analyzed. The ptsP mutant was characterized phenotypically, and
complementation studies were performed to confirm that the interrupted
gene itself was required for in vivo and in vitro virulence.
Bacteria and plasmids.
L. pneumophila
serogroup1 strain AA100jm (12) is a spontaneous
streptomycin-resistant mutant of strain 130b (28) which is
virulent in guinea pigs, macrophages, and amoebae (12,
29). Clones 47:3h and 47:4a are ptsP mutants, and
clone 47:2f is a dotO mutant of AA100jm. dotO is
within the icm/dot gene cluster and involved in
intracellular growth and evasion of the endocytic pathway
(1). They were made by transposon mutagenesis of AA100jm using Tn903HT (Tn903 harboring a signature tag)
(12). L. pneumophila strains were grown at
35°C in a humidified incubator either on MOPS
[3-(N-morpholino)propanesulfonic acid]-buffered charcoal yeast extract agar medium supplemented with Nucleic acid manipulation.
All nucleic acid manipulations
were accomplished according to standard molecular biology techniques
(2).
Complete sequencing of the ptsP gene.
Genomic
DNA from mutant clone 47:3h (AA100jm
ptsP838::Tn903HT) or mutant clone 47:4a
(AA100jm ptsP1240::Tn903HT)
was digested with restriction enzymes known not to cut the transposon
insertion upstream of the kanamycin resistance gene (Kmr)
cassette. Digested DNA was ligated into pUC18, which was appropriately digested. E. coli strain XL-1 Blue was transformed with the
ligated product by electroporation. Plasmid DNA of Kmr
transformants was restriction digestion mapped to confirm proper insertion of the desired DNA fragment into the plasmid. Plasmid DNA was
purified by using a Quiagen spin filter (Quiagen), and the insert DNA
was sequenced by a primer walking technique. An ABI Big Dye Taq FS
terminator sequencing kit (Applied Biosystems) was used to synthesize
the dye-terminated DNA, which then was sequenced by using an ABI 377 automated sequencer (University of Pennsylvania Sequencing Facility).
Whole sequence data were analyzed and aligned using SeqMan II software,
version 4.03 (DNASTAR Inc., Madison, Wis.). GenBank sequence database
searching was performed with the BLASTX and BLASTN search algorithms.
Deduced amino acid sequences were analyzed with Motif
(http://www.motif.genome.ad.jp) and SOSUI
(http://azusa.proteome.bio.tuat.ac.jp/sosui/). Multiple sequence alignments were performed using Megalign, version 4.03, with
the Jotun Hein method (DNASTAR).
Macrophages and alveolar epithelial cells.
Guinea pig
alveolar macrophages were prepared as previously described
(12) and cultured in medium 199 (M199; Life Technologies) supplemented with 10% fetal bovine serum (Bio Whittaker, Walkersville, Md.). A549, a human alveolar epithelial cell line received as a gift
from Michael Beers, was maintained in M199-10% fetal bovine serum.
A549 cells were harvested at logarithmic growth phase, using 10 mM
EDTA-phosphate-buffered saline (PBS) solution and 5% trypsin-PBS. The
alveolar epithelial cells (1.25 × 105/well) were
cultured overnight in 24-well culture tray in 5% CO2 air
at 37°C and then used for experiments. Murine bone marrow-derived macrophages were prepared from A/J mice as reported previously (34).
Serum killing assay.
Normal serum was collected from healthy
guinea pigs. The antibody titer of the serum against L. pneumophila SG1 was 1:32, as measured by indirect
immunofluorescence, as described previously, but modified to detect
guinea pig antibodies by use of fluorescein-labeled goat anti-guinea
pig immunoglobulin G antibody (ICN Biomedicals, Aurora, Ohio)
(8). Immune guinea pig serum was obtained from animals
infected with sublethal doses of L. pneumophila and had an
indirect immunofluorescence assay titer of 1:256. Serum was heat
inactivated at 56°C for 30 min when needed. Bacteria (108
CFU/ml) were incubated in phosphate buffer supplemented with Ca2+ and Mg2+ (pH 7.35) with or without serum
at 37°C for 1 h. The suspensions were then diluted in decimal
dilutions with Mueller-Hinton broth (MHB) and plated onto BCYE- Neutrophil killing assay.
Human peripheral polymorphonuclear
leukocytes were purified by density gradient centrifugation and dextran
sedimentation as described previously (4). The killing
assay was performed using 20% human serum, as previously described
(18), with one exception. M199 was used to suspend the
bacteria and neutrophils rather than Hanks' balanced salt solution, as
the Legionella bacteria were killed by the salt solution.
Determination of flagellation.
Plate-grown
Legionella bacteria were suspended in sterile distilled
water and stained for the presence of flagellae, using the Ryu stain
(Remel Laboratories, Lenexa, Kans.), as described previously (9,
22).
Invasion assay.
Guinea pig alveolar macrophages were
infected with bacterial (multiplicity of infection [MOI] at 50) in
24-well microplates, after which the plates were centrifuged at
100 × g for 8 min at room temperature. The infected
macrophages were then incubated at 37°C in 5% CO2 air
for 2 h. The infected macrophages were washed with warm M199 three
times and incubated with or without gentamicin (50 µg/ml) for 1 h. The macrophages were then washed with warm M199 three times. The
infected macrophages were harvested at indicated points in sterile
distilled water and then lysed by vortex mixing for 1 min. The lysate
was plated quantitatively on BCYE- Intracellular growth assay.
Macrophages or alveolar
epithelial cells were prepared as described above, infected with
L. pneumophila (MOI of 0.1), and then incubated in 5%
CO2 air at 37°C. Culture supernatants were harvested at
indicated times, diluted appropriately with MHB, and then plated onto
BCYE- Pore formation assay.
L. pneumophila
contact-induced pore formation in the macrophage membrane was assayed
as described previously (40). In these assays, L. pneumophila was added at the given MOIs to 1.5 × 105 mouse bone marrow-derived macrophages plated on
coverslips in 24-well microplates. Rabbit anti-L.
pneumophila polyclonal antibody was added to each well. The tissue
culture plates were centrifuged at 150 × g for 5 min
at room temperature and incubated for 1 h at 37°C. The
coverslips were then stained with ethidium bromide (25 µg/ml) and
acridine orange (5 µg/ml). All cells will stain with acridine orange,
whereas an intact macrophage membrane will exclude ethidium bromide.
Pore-forming activity was measured as the percentage of macrophages
that stain positive with ethidium bromide. Coverslips were examined
with a Zeiss Axioplan II microscope. A rhodamine bandpass filter set
was used to detect ethidium bromide, and a fluorescein isothiocyanate
bandpass filter set was used to detect acridine orange staining.
Phagosome trafficking assay.
Trafficking of phagosomes
harboring L. pneumophila within murine bone marrow-derived
macrophages was assayed as described previously (34).
Briefly, the macrophages (8 × 104) on glass
coverslips in a 24-well microplate were infected with L. pneumophila at an MOI of 50. The plates were centrifuged at 150 × g for 5 min at room temperature to optimize
bacterial uptake. Infected macrophages were incubated for 30 min at
37°C in 5% CO2 air; then the cells were washed and fixed
in paraformaldehyde. The coverslips were immersed in ice-cold methanol
for 10 s to permeabilize the cells and then blocked in PBS
containing 2% goat serum for 1 h. Lysosomes were stained with
anti-murine Lamp-1 rat antibody (1D4B; 1:250), followed by fluorescein
isothiocyanate-labeled anti-rat immunoglobulin secondary antibody
(1:250). Bacteria were stained with 4',6-diamidino-2-phenylindole. All
antibody washes were in PBS. Coverslips were inverted onto 2 µl of
mounting media before viewing. Bacterial phagosomes were scored for
Lamp-1 staining by standard epifluorescence microscopy.
Electron microscopic observation.
Guinea pig alveolar
macrophages were cultured on sterile plastic coverslips and then
infected with L. pneumophila (MOI of 0.1). The infected
cells were incubated for 2 or 3 days. Then the infected macrophages
were fixed with 2% glutaraldehyde in PBS and washed with ice-cold PBS.
Fixed materials were processed using standard technique and examined in
an electron microscope (Biomedical Image Core Facility, University of Pennsylvania).
Trans-complementation of L. pneumophila ptsP
mutation.
A DNA fragment containing the L. pneumophila
ptsP gene was amplified by the PCR from L. pneumophila
AA100jm genomic DNA, using the upstream sense primer (mu-3h10;
5'-AATACTGCAGTGGGTGGATTTTCAT-3') and the
downstream antisense primer (mu-3h11;
5'-TTAGGATCCCGCCATTATTCCTG-3'). BamHI
and PstI sites respectively (underlined), were incorporated into these primers. Amplification was performed using Vent polymerase (New England Biolabs, Beverly, Mass.). The amplified products of the
ptsP gene were digested with BamHI and
PstI and then ligated with pSU2719, which had been digested
with appropriate enzymes and dephosphorylated. E. coli XL-1
Blue was transformed with the ligated product by electroporation.
Plasmid DNA of chloramphenicol-resistant (Cmr)
transformants was restriction digested-mapped to confirm proper insertion of the desired DNA fragment into the plasmid. The cloned ptsP gene was sequenced as stated above to verify no
erroneous incorporation of nucleotides during amplification. A single
clone containing the whole ptsP gene was picked for further
study, and the plasmid was designated pHT28a. Plasmid DNA was purified
by using a Quiagen spin filter. The ptsP mutant of AA100jm,
clone 3h, was transformed with pHT28a by electroporation. Plasmid DNAs from several Cmr transformants were restriction digestion
mapped to confirm the presence of the desired plasmid. One of the
transformants containing the desired plasmid was picked for further
studies and designated HT31a. PCR testing of HT31a using
ptsP-specific primers showed that it contained the
full-length ptsP gene, in contrast to the noncomplemented
mutant. Empty pSU2719 was electroporated into the mutant (clone 47:3h)
as well the parent (AA100jm) to serve as negative controls; these were
designated HT32a and HT34a, respectively.
Animal model.
The guinea pig model of L. pneumophila pneumonia was used as described previously
(10). L. pneumophila was grown in BYE- Immunoblot analysis.
To identify expression of DotA protein
and IcmX protein in the ptsP mutant and its parent, Western
blotting was used (27, 34). Plate-grown colonies of
bacteria were sonicated (for DotA) or boiled (for IcmX), then lysed in
Laemmli sample buffer, and applied to a sodium dodecyl
sulfate-polyacrylamide gel. Separated proteins were transferred
electrophoretically to Immobilon-P membranes (Millipore). The membranes
were probed with a polyclonal rabbit antibody against DotA (gift from
Craig R. Roy; 1:1,000) or a polyclonal rabbit antibody against IcmX
(gift from Craig R. Roy; 1:500) and alkaline-phosphatase conjugated
anti-rabbit secondary antibody (Boehringer Mannheim). The proteins were
visualized using nitroblue tetrazolium and
5-bromo-4-chloro-3-indolylphosphate. All blocking and antibody
dilutions were performed in 1 × PBS containing 5% nonfat dry milk and
0.1% Tween 20.
Nucleotide sequence accession number.
The ptsP
sequence has been deposited in the GenBank database at the National
Center for Biotechnology Information under accession number AF181870.
Complete sequence of the ptsP gene.
Sequencing of
the region surrounding the transposon insertion sites of mutant clones
47:3h and 47:4a was completed and verified for a region 3,624 bp in
length. The largest open reading frame (ORF1) consisted of 2,295 bp.
The two transposon insertion sites were within this ORF, 827 and 1241 bp downstream of the start site, for clones 47:3h and 47:4a,
respectively (Fig. 1). No significant homology was discovered with sequences deposited in the nonredundant GenBank database, using the BLASTN search algorithm. However, use of
the BLASTX search algorithm revealed that ORF1 had high homology with
the EINtrptsP gene of Pseudomonas
aeruginosa (score, 825; identities, 413/759 [54%]; positives,
551/759 [72%]; expected, 0.0), the phosphotransferase EI of A. vinelandii (822; 413/759 [54%]; 558/759 [73%]; 0.0), and the
ptsP EINtr of E. coli (610; 337/767
[43%]; 471/767 [56%]; e
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.4782-4789.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Potential Virulence Role of the Legionella
pneumophila ptsP Ortholog
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
54 -dependent transcriptional initiation of genes
concerned with organic nitrogen utilization (31). NPr and
EIIANtr are encoded in the rpoN operon,
suggesting that ptsP is involved in the transcriptional
regulation of rpoN-dependent operons (31).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-ketoglutarate
(BCYE-
) (11) or in ACES
[N-(2-acetamido)-2-aminoethanesulfonic acid]-buffered yeast extract broth supplemented with
-ketoglutarate (BYE-
) (11). E. coli K-12 and K29 were serum sensitive
and serum resistant, respectively (17), and were gifts
from Marcus Horwitz. E. coli strain XL-1 Blue (Stratagene)
was grown at 37°C either on Luria-Bertani agar or in Luria-Bertani
broth. Selective antimicrobial agents were added to the growth media
when appropriate and included kanamycin (30 µg/ml), streptomycin (200 µg/ml), and chloramphenicol (10 [L. pneumophila] or 30 [E. coli] µg/ml). Plasmid pSU2719 (26) was
a gift from Nicolas Cianciotto. Plasmid pSU2719 carries a P15A
replicon, chloramphenicol acetyltransferase, and LacZ
and can
multiply within L. pneumophila. Plasmid pUC18 was purchased from Life Technologies, Gaithersburg, Md.
agar
plates, which were incubated for 3 days. Surviving bacteria were
enumerated by counting CFU on the plates.
medium. A separate experiment
showed that there were no significant increases in intracellular
bacterial concentrations during the 1-h gentamicin incubation period
(data not shown).
agar plates. In some experiments the cultured cells were lysed
in the tissue culture wells either by low-energy sonication or by
hypotonic lysis with distilled water; neither method affects the
viability of L. pneumophila.
broth
under the appropriate selective conditions and was diluted in sterile
water at a concentration of 3.3 × 106 CFU/ml;
106 CFU was injected into the surgically exposed tracheas
of Hartley strain male guinea pigs weighing ~250 g. The animals were
killed 2 days later. The right lower lung lobe and spleen were removed aseptically, weighed and ground in MHB, and then diluted in the same
broth type in decimal dilutions. Diluted tissue homogenates were plated
onto BCYE-
with or without kanamycin. Another experiment extended
the postinfection observation time to 7 days.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
173). ORF1 was designated
L. pneumophila ptsP. All four of these homologous proteins
shared many conserved regions, especially the region around the
histidine residue that is the putative phosphorylation site. Also
highly conserved was the region that represents the motif of the
phosphoenolpyruvate-utilizing enzyme signature 2 (Prosite PS00472;
positions 628 to 646 in amino acid sequence of L. pneumophila
ptsP). Both the N-terminal and C-terminal domains of the E. coli EINtr were highly conserved in the L. pneumophila ptsP. SOSUI analysis (15) predicted that
L. pneumophila ptsP is a soluble protein and located in the
inner membrane.

View larger version (9K):
[in a new window]
FIG. 1.
Scheme of the ptsP operon. Each arrow
represents an ORF. The transposon insertion sites of mutants 47:3h and
47:4a are shown as arrowheads. The gene region used for complementation
is shown as a halftone box. The nucleotide numbering refers to that of
L. pneumophila ptsP as published in GenBank
(AF181870).
46;
AF116285). These ptsP and invA orthologs are in
contiguous regions and in the same orientation in both bacteria
(39). ORF2 was also homologous to MutT-like proteins in a
variety of other bacteria and to invA of Rickettsia
prowazekii and other bacteria. No putative promoter regions were
identified immediately upstream of the ptsP ortholog, but a
possible promoter was found starting 39 bp upstream of ORF2
(http://www.fruitfly.org/seq_tools/promoter.html).
Growth of the ptsP mutants and complemented mutants in
guinea pigs.
Intrapulmonary growth of two different
ptsP mutants was assessed using a guinea pig pneumonia
model. Two days after intratracheal inoculation of guinea pigs, the
parent strain multiplied by at least 100-fold in the lungs, whereas
neither of the mutants multiplied in the lungs (Fig.
2). Parent, but not mutant, strain
bacteria were recovered in high concentrations from the spleens. Three of four animals inoculated with the mutant bacteria had no detectable bacteria recovered from their spleens, and the fourth animal's spleen
contained bacteria in a concentration just above the detection limit of
100 CFU/spleen. Concentrations of the mutant in the lung and spleen
were about 1 and <0.02%, respectively, of the parent concentrations
for the same organs in different animals.
|
|
+ 1.5°C change from baseline), and exhibited weight loss (mean,
21%
from baseline); three of four animals died of pneumonia by day 5 postinfection, and one survived to day 7. In contrast, all four animals
infected with the mutant bacterium appeared clinically well, survived
to 7 days postinfection, and gained weight (mean, +18% from baseline).
The only evidence of disease in the animals infected with the mutant
bacterium was a slight (mean, +0.4°C), though statistically
significant (P = 0.01, paired t test),
increase in body temperature on postinfection day 2 only. Of note, this
slight fever peak occurred 1 day later than did the maximum fever
observed for the parent-infected animals. Postmortem findings in the
two animal groups showed that the animals infected with the
ptsP mutant had significantly lower lung weights (mean, 6.2 versus 3.0 g), bacterial lung counts (mean, 2.4 × 109
versus 6.7 × 103 CFU/lung), and bacterial spleen
counts (9.6 × 103 versus 4.5 × 101
CFU/spleen) than did animals infected with the parent strain (P < 0.03 for all comparisons). These findings show
that ptsP is required for full virulence of L. pneumophila in guinea pigs and that delayed animal virulence is
not observed for infection with a ptsP mutant.
Intracellular growth and uptake characteristics.
To determine
if the reduced guinea pig virulence of the ptsP mutant was
due to an intracellular growth defect, we examined its growth within
explanted guinea pig alveolar macrophages and a human alveolar
epithelial cell line. The parent strain grew well within both cell
types, contrast to the deficient growth of the mutant (Fig.
4). In alveolar macrophages, the
ptsP mutant supernatant concentration decreased on day 1 in
comparison to its starting concentration and that of the parent strain,
but there after the mutant grew as fast as the parent (Fig. 4A).
|
Effect of ptsP transcomplementation on
intracellular growth.
To determine if transcomplementation
of the ptsP mutant restored its ability to grow within
cells, it was used to infect guinea pig alveolar macrophages and
A549 cells. The transcomplemented mutant (HT31a) grew within
macrophages almost as well as its parent containing empty vector, HT34a
(Fig. 5A). Complementation of
ptsP also restored growth of the mutant within A549 cells to
levels intermediate between the mutant containing empty vector and the parent with empty vector (Fig. 5B).
|
Extracellular phenotypic characterization of the mutant.
Extracellular growth of the ptsP mutant (clone 47:3h) in
BYE-
broth was the same as was observed for the parent type strain (AA100jm) (data not shown). We previously showed that both clones 47:3h
and 47:4a are prototrophic (34). Microscopically, the parent strain appeared as short thin rods, while the ptsP
mutant was longer, but as thin as its parent, at log-growth phase. At stationary phase (optical density at 660 nm of >1.0), more filamentous forms were seen with the ptsP mutant than wild type. The
mutant showed the same Sudan black B-positive deposits as the parent strain, both at log phase and at stationary phase. Both the parent and
mutant produced monopolar and dipolar flagella. Colonial morphology of
the mutants and the parent was indistinguishable.
Pore formation, intracellular trafficking, and phagosome ultrastructural morphology. To determine if the initial slow growth of the ptsP mutant was related to decreased pore formation of macrophages, bacterium-induced pore formation in murine bone marrow-derived macrophages was compared to that of the parent strain, as well as to that of a dotO mutant, using cell permeability to ethidium bromide as a marker of cell pore formation.
DotO mutants are unable to form pores in macrophages (1). Both the parent and ptsP mutant formed pores in the majority of macrophages studied, while macrophages infected with the dotO mutant did not form pores. At an MOI of 1,000, the ptsP mutant formed pores in 60.0% ± 10.8% of cells, versus 79.3% ± 3.0% and 1.6% ± 1.0% for cells infected by the parent and dotO mutants, respectively. At an MOI of 10, the frequencies of cell pore formation were 52.9% ± 7.5%, 60.7% ± 25.3%, and 2.0% ± 1.1% for the ptsP mutant, parent, and dotO mutant, respectively. These results show that the ptsP mutation had no effect on cytotoxicity. L. pneumophila normally blocks maturation of its phagosome (16), and a defect in this ability could affect intracellular growth. The ability of the ptsP mutant to inhibit the colocalization of the lysosomal membrane marker Lamp-1 within the phagosome was assessed by microscopy using murine bone marrow-derived macrophages. Thirty minutes after infection, only 8.7% (10/114) of phagosomes harboring the ptsP mutant (clone 47:3h) and 5.5% (6/109) of the parent strain were colocalized with Lamp-1, in contrast to the 73.8% (93/126) colocalization frequency for phagosomes containing the dotO mutant. This result indicated that the ptsP mutation did not impair the ability of the bacterium to inhibit phagosome maturation. The ultrastructure of phagosomes containing the ptsP mutant or its parent was examined using guinea pig alveolar macrophages to determine if mutant-containing phagosomes were ribosome studded, as is observed for wild-type L. pneumophila. Two days after infection of macrophages with the parent strain (MOI = 0.1), 14 (38.9%) of 36 infected macrophages contained ribosome-studded phagosomes (Fig. 6A). Too few macrophages to score by electron microscopy were infected with the ptsP mutant at the same MOI 2 days after inoculation. Three days after infection of macrophages with the mutant, most macrophages were infected; among 40 macrophages infected, 15 contained ribosome-studded phagosomes (37.5%) (Fig. 6B). The phagosomes containing the ptsP mutant appeared to be slightly more spacious than the phagosomes containing the parent strain, but quantitative morphometric studies were not performed.
|
DotA and IcmX production. To determine if the ptsP mutation had an effect on the dot/icm system, we examined DotA protein and Icm X protein expression of the mutant. Crude lysates of both the parent and ptsP mutant applied in equivalent protein amounts to the polyacrylamide gel showed apparently identical amounts of DotA by immunoblot assay. Similarly, boiled samples of both the parent and ptsP mutant and F2345 applied in equivalent protein amounts to the polyacrylamide gel showed apparently identical amounts of IcmX protein (data not shown). These data indicate that the ptsP mutation does not affect dotA and icmX regulation.
| |
DISCUSSION |
|---|
|
|
|---|
We have demonstrated that the L. pneumophila ptsP gene is an important virulence factor for cell and guinea pig infection. Mutations at two different sites in the gene dramatically reduced the ability of the bacterium to multiply in guinea pig lungs and also eliminated the extrapulmonary invasiveness of the bacterium. This reduced virulence is attributable to the reduced ability of the mutant bacterium to multiply within macrophages without affecting its ability to invade cells. The architecture of the L. pneumophila ptsP gene is very similar to that found in P. aeruginosa in that both the ptsP and invA orthologs are in contiguous regions, and in the same orientation (39). There is also considerable homology between the L. pneumophila, P. aeruginosa (39), and A. vinelandii (36) orthologs of the ptsP gene itself, indicating a common genetic origin.
Proof that the ptsP mutation itself is responsible for the reduced-virulence phenotype was provided by the complementation studies. Transcomplementation of ptsP increased the virulence of the noncomplemented mutant about 50-fold in cultured cells and 10-fold and 250-fold in guinea pig lung and spleen, respectively, and fully restored the clinical virulence of the bacterium. In comparison with the parent strain, transcomplementation of ptsP almost completely restored the ability of the mutant to grow within alveolar epithelial cells and reversed its initial growth defect within alveolar macrophages. Also, ptsP transcomplementation almost completely restored the ability of the mutant to multiply in the lung and invade the spleen of guinea pigs. We attribute partial, rather than full, restoration of the mutant to the parenteral phenotype to plasmid loss in the absence of antibiotic selection in the animal and cellular infection models. There is no practical way to maintain chloramphenicol selection in vivo or in cell culture, as chloramphenicol appears to be ineffective against normally Cms L. pneumophila in both systems (7). Nonantimicrobial selective pressure favored the growth of the complemented mutant, in that it was more able to multiply in tissues when it contained the plasmid than when it lacked it; this is demonstrated by the greater than 10-fold difference in plasmid retention between the complemented mutant and the mutant with the empty plasmid.
An equally valid alternative explanation for the incomplete restoration of the parenteral virulence phenotype by transcomplementation is that there was a polar effect on downstream virulence genes in the same operon. Examination of the published sequence of a related L. pneumophila serogroup 1 strain shows that there are two large ORFs downstream of ptsP in what may be the same operon (http://genome3.cpmc.columbia.edu/%7Elegion/). Since the ptsP trancomplementation by itself had a dramatic effect on the virulence phenotype, these putative downstream virulence genes would have to act in concert with ptsP to cause full virulence. Several attempts at making an unmarked nonpolar mutation of ptsP were unsuccessful in our hands, precluding definitive resolution of this point.
Our studies indicate that the ptsP mutant invades macrophages normally and hence that its intracellular multiplication is slowed due to poor growth once the bacterium is intracellular. This poor growth could be due either to growth of only a small fraction of invading bacteria or to a longer than normal lag phase of growth of all the invading bacteria. In alveolar macrophages the bacteria eventually multiply to levels observed for the parent strain, indicating that the intracellular growth rate normalizes after a long lag. Normalization of the growth rate is consistent with the results of the ultrastructural and endosome maturation studies, which showed that the mutant resides in a parenteral-type phagosome with inhibition of endosomal maturation. The significance of the slightly more spacious nature of the phagosomes containing the mutant is unknown. Taken together, these findings suggest that the intracellular multiplication defect is an early event, eventually bypassed by unknown factors. The delayed normalization of growth within macrophages did not have an in vivo correlate, probably because guinea pig host defenses develop quickly, enabling the host defenses to overcome an initially slowly growing bacterium.
Growth of L. pneumophila within alveolar epithelial cells has been suggested to be a virulence determinant, in that bacterial mutants capable of growing within alveolar epithelial cells, but not alveolar macrophages, retained their virulence in a mouse pneumonia model (14). Defective growth of the ptsP mutant in alveolar epithelial cells may partially or wholly explain why the guinea pig virulence of the mutant is so attenuated, despite the ability of the bacterium to eventually multiply normally in alveolar macrophages and to possess the parenteral phagosomal phenotype. Alteration in the regulation of the dot/icm system is not an explanation for the reduced virulence of the ptsP mutant. Unlike dot/icm mutants, the ptsP mutant established ribosome-studded phagosomes, normally inhibited endosomal maturation, and formed host cell membrane pores. In addition, DotA and IcmX appear to be normally produced by the ptsP mutant.
The function and the pathogenic and nonpathogenic roles of the L. pneumophila ptsP gene are unknown. The deduced amino acid sequences of known ptsP homologs and L. pneumophila ptsP were well conserved. Among them, E. coli ptsP has been investigated most intensively. The E. coli ptsP gene encodes EINtr, which is thought to serve a sensory function linking carbon and nitrogen metabolism (33). In addition, EINtr may play a role in the transcriptional regulation of rpoN-dependent operons (31). A variety of bacterial virulence traits are linked to rpoN-dependent operons, including Pseudomonas syringae virulence for tomato plants (23), Vibrio anguillarum fish virulence (30), Agrobacterium tumefaciens plant virulence (5), and V. cholerae virulence for mice (21). We speculate that the L. pneumophila ptsP ortholog is involved in signal transduction for expression of a virulence factor, which may be through regulation of the rpoN operon.
There are few studies on the phenotypic effects of ptsP
mutations of other bacteria. Mutation of the P. aeruginosa
ptsP ortholog results in reduced virulence for
Caenorhabditis elegans and mice, by an unknown mechanism
(38, 39). Mutational inactivation of the A. vinelandii ptsP ortholog affects poly-
-hydroxybutyrate accumulation (36). L. pneumophila is known to
deposit
-hydroxybutyrate within its cytoplasm as a nutrition source
for long-term starvation survival (20). Our results show
that the L. pneumophila ptsP gene is apparently not
responsible for
-hydroxybutyrate accumulation, as the broth-grown
ptsP mutant showed the same amount of Sudan black B-positive
deposits as its parent.
In summary, this study demonstrates that the ptsP ortholog is required for full expression of virulence of L. pneumophila in vivo. The ptsP mutation results in an initial defect of growth within macrophages and inability to grow within alveolar epithelial cells. The sequence homology search suggests that the gene may be involved in signal transduction of virulence, which requires further study to elucidate the mechanism. Such studies will give us new insights into the molecular pathogenesis of L. pneumophila.
| |
ACKNOWLEDGMENTS |
|---|
We thank Martha Edelstein for excellent technical assistance; Craig Roy for helpful discussion, provision of reagents, and instruction in the intracellular trafficking experiments; and Lalita Ramakrishnan for critical review of the manuscript.
Futoshi Higa was supported by a study grant from Japanese Ministry of Education, Sports, and Culture.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Clinical Microbiology Laboratory, 4 Gates, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, 3400 Spruce St., Philadelphia, PA 19104-4283. Phone: (215) 662-6651. Fax: (215) 662-6655. E-mail: phe{at}mail.med.upenn.edu.
Editor: V. J. DiRita
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Andrews, H. L.,
J. P. Vogel, and R. R. Isberg.
1998.
Identification of linked Legionella pneumophila genes essential for intracellular growth and evasion of the endocytic pathway.
Infect Immun.
66:950-958 |
| 2. | Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1995. Current protocols in molecular biology. Wiley, New York, N.Y. |
| 3. | Berger, K. H., and R. R. Isberg. 1993. Two distinct defects in intracellular growth complemented by a single genetic locus in Legionella pneumophila. Mol. Microbiol. 7:7-19[Medline]. |
| 4. | Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Investig. Suppl. 97:77-89[Medline]. |
| 5. | Chesnokova, O., J. B. Coutinho, I. H. Khan, M. S. Mikhail, and C. I. Kado. 1997. Characterization of flagella genes of Agrobacterium tumefaciens, and the effect of a bald strain on virulence. Mol. Microbiol. 23:579-590[CrossRef][Medline]. |
| 6. | Coers, J., C. Monahan, and C. R. Roy. 1999. Modulation of phagosome biogenesis by Legionella pneumophila creates an organelle permissive for intracellular growth. Nat. Cell Biol. 1:451-453[CrossRef][Medline]. |
| 7. | Edelstein, P. H. 1995. Antimicrobial chemotherapy for legionnaires' disease: a review. Clin. Infect. Dis. 21(Suppl 3):5265-5276. |
| 8. | Edelstein, P. H. 1997. Detection of antibodies to Legionella spp., p. 502-509. In N. R. Rose, E. C. de Macario, J. D. Folds, H. C. Lane, and R. M. Nakamura (ed.), Manual of clinical laboratory immunology, 5th ed. American Society Microbiology, Washington, D.C. |
| 9. | Edelstein, P. H. 1985. Legionnaires' disease laboratory manual. National Technical Information Service, Chantilly, Va. |
| 10. | Edelstein, P. H., K. Calarco, and V. K. Yasui. 1984. Antimicrobial therapy of experimentally induced Legionnaires' disease in guinea pigs. Am. Rev. Respir. Dis. 130:849-856[Medline]. |
| 11. |
Edelstein, P. H., and M. A. Edelstein.
1993.
Comparison of three buffers used in the formulation of buffered charcoal yeast extract medium.
J. Clin. Microbiol.
31:3329-3330 |
| 12. |
Edelstein, P. H.,
M. A. Edelstein,
F. Higa, and S. Falkow.
1999.
Discovery of virulence genes of Legionella pneumophila by using signature tagged mutagenesis in a guinea pig pneumonia model.
Proc. Natl. Acad. Sci. USA
96:8190-8195 |
| 13. |
Edelstein, P. H., and R. D. Meyer.
1984.
Legionnaires' disease. A review
Chest
85:114-120 |
| 14. | Gao, L. Y., B. J. Stone, J. K. Brieland, and Y. Abu Kwaik. 1998. Different fates of Legionella pneumophila pmi and mil mutants within macrophages and alveolar epithelial cells. Microb. Pathog. 25:291-306[CrossRef][Medline]. |
| 15. |
Hirokawa, T.,
S. Boon-Chieng, and S. Mitaku.
1998.
SOSUI: classification and secondary structure prediction system for membrane proteins.
Bioinformatics
14:378-379 |
| 16. |
Horwitz, M. A.
1983.
The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes.
J. Exp. Med.
158:2108-2126 |
| 17. | Horwitz, M. A., and S. C. Silverstein. 1980. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J. Clin. Investig. 65:82-94. |
| 18. |
Horwitz, M. A., and S. C. Silverstein.
1981.
Interaction of the legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. II. Antibody promotes binding of L. pneumophila to monocytes but does not inhibit intracellular multiplication.
J. Exp. Med.
153:398-406 |
| 19. | Horwitz, M. A., and S. C. Silverstein. 1980. Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes. J. Clin. Investig. 66:441-450. |
| 20. |
James, B. W.,
W. S. Mauchline,
P. J. Dennis,
C. W. Keevil, and R. Wait.
1999.
Poly-3-hydroxybutyrate in Legionella pneumophila, an energy source for survival in low-nutrient environments.
Appl. Environ. Microbiol.
65:822-827 |
| 21. | Klose, K. E., and J. J. Mekalanos. 1998. Distinct roles of an alternative sigma factor during both free-swimming and colonizing phases of the Vibrio cholerae pathogenic cycle. Mol. Microbiol. 28:501-520[CrossRef][Medline]. |
| 22. |
Kodaka, H.,
A. Y. Armfield,
G. L. Lombard, and V. R. Dowell, Jr.
1982.
Practical procedure for demonstrating bacterial flagella.
J. Clin. Microbiol.
16:948-952 |
| 23. | Lorang, J. M., and N. T. Keen. 1995. Characterization of avrE from Pseudomonas syringae pv. tomato: a hrp-linked avirulence locus consisting of at least two transcriptional units. Mol. Plant Microbe Interact. 8:49-57[Medline]. |
| 24. |
Marra, A.,
S. J. Blander,
M. A. Horwitz, and H. A. Shuman.
1992.
Identification of a Legionella pneumophila locus required for intracellular multiplication in human macrophages.
Proc. Natl. Acad. Sci. USA
89:9607-9611 |
| 25. | Marra, A., M. A. Horwitz, and H. A. Shuman. 1990. The HL-60 model for the interaction of human macrophages with the Legionnaires' disease bacterium. J. Immunol. 144:2738-2744[Abstract]. |
| 26. | Martinez, E., B. Bartolome, and F. de la Cruz. 1988. pACYC184-derived cloning vectors containing the multiple cloning site and lacZ alpha reporter gene of pUC8/9 and pUC18/19 plasmids. Gene 68:159-162[CrossRef][Medline]. |
| 27. |
Matthews, M., and C. R. Roy.
2000.
Identification and subcellular localization of the Legionella pneumophila IcmX protein: a factor essential for establishment of a replicative organelle in eukaryotic host cells.
Infect. Immun.
68:3971-3982 |
| 28. | Meyer, R. D., P. H. Edelstein, B. D. Kirby, M. H. Louie, M. E. Mulligan, A. A. Morgenstein, and S. M. Finegold. 1980. Legionnaires' disease: unusual clinical and laboratory features. Ann. Intern. Med. 93:240-243. |
| 29. | Moffat, J. F., P. H. Edelstein, D. P. Regula, Jr., J. D. Cirillo, and L. S. Tompkins. 1994. Effects of an isogenic Zn-metalloprotease-deficient mutant of Legionella pneumophila in a guinea-pig pneumonia model. Mol. Microbiol. 12:693-705[CrossRef][Medline]. |
| 30. |
O'Toole, R.,
D. L. Milton,
P. Horstedt, and H. Wolf-Watz.
1997.
RpoN of the fish pathogen Vibrio (Listonella) anguillarum is essential for flagellum production and virulence by the water-borne but not intraperitoneal route of inoculation.
Microbiology
143:3849-3859 |
| 31. |
Powell, B. S.,
D. L. Court,
T. Inada,
Y. Nakamura,
V. Michotey,
X. Cui,
A. Reizer,
M. H. Saier, Jr., and J. Reizer.
1995.
Novel proteins of the phosphotransferase system encoded within the rpoN operon of Escherichia coli. Enzyme IIANtr affects growth on organic nitrogen and the conditional lethality of an erats mutant.
J. Biol. Chem.
270:4822-4839 |
| 32. |
Rabus, R.,
J. Reizer,
I. Paulsen, and M. H. Saier, Jr.
1999.
Enzyme I(Ntr) from Escherichia coli. A novel enzyme of the phosphoenolpyruvate-dependent phosphotransferase system exhibiting strict specificity for its phosphoryl acceptor. NPr.
J. Biol. Chem.
274:26185-26191 |
| 33. | Reizer, J., A. Reizer, M. J. Merrick, G. Plunkett, III, D. J. Rose, and M. H. Saier, Jr. 1996. Novel phosphotransferase-encoding genes revealed by analysis of the Escherichia coli genome: a chimeric gene encoding an enzyme I homologue that possesses a putative sensory transduction domain. Gene 181:103-108[CrossRef][Medline]. |
| 34. | Roy, C. R., K. H. Berger, and R. R. Isberg. 1998. Legionella pneumophila DotA protein is required for early phagosome trafficking decisions that occur within minutes of bacterial uptake. Mol. Microbiol. 28:663-674[CrossRef][Medline]. |
| 35. |
Sadosky, A. B.,
L. A. Wiater, and H. A. Shuman.
1993.
Identification of Legionella pneumophila genes required for growth within and killing of human macrophages.
Infect. Immun.
61:5361-5373 |
| 36. |
Segura, D., and G. Espin.
1998.
Mutational inactivation of a gene homologous to Escherichia coli ptsP affects poly- -hydroxybutyrate accumulation and nitrogen fixation in Azotobacter vinelandii.
J. Bacteriol.
180:4790-4798 |
| 37. | Swanson, M. S., and R. R. Isberg. 1995. Association of Legionella pneumophila with the macrophage endoplasmic reticulum. Infect. Immun. 63:3609-3620[Abstract]. |
| 38. |
Tan, M. W.,
S. Mahajan-Miklos, and F. M. Ausubel.
1999.
Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis.
Proc. Natl. Acad. Sci. USA
96:715-720 |
| 39. |
Tan, M. W.,
L. G. Rahme,
J. A. Sternberg,
R. G. Tompkins, and F. M. Ausubel.
1999.
Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors.
Proc. Natl. Acad. Sci. USA
96:2408-2413 |
| 40. | Zuckman, D. M., J. B. Hung, and C. R. Roy. 1999. Pore-forming activity is not sufficient for Legionella pneumophila phagosome trafficking and intracellular growth. Mol. Microbiol. 32:990-1001[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»